Albumin Nanoparticles Harness Activated Neutrophils to Cross Vascular Barriers for Targeted Subcutaneous and Orthotopic Colon Cancer Therapy
Source abstract
Abstract
Colorectal cancer (CRC) therapy faces challenges due to limited drug penetration across the blood–tumor barrier. Neutrophils, with their natural ability to migrate to inflamed and tumor sites, offer a promising cell-mediated delivery strategy. This study developed albumin nanoparticles loaded with 6-shogaol (NPs/6-shogaol) and utilized activated neutrophils as carriers to transport the nanoparticles across vascular barriers for colon cancer therapy. The physicochemical properties, biocompatibility, and targeting efficiency of the NPs were evaluated in vitro and in vivo. The formulated NPs/6-shogaol exhibited favorable physicochemical properties, including a uniform nano-scale size (~150 nm), negative zeta potential, and high drug loading efficiency. In both subcutaneous and orthotopic colon cancer models, neutrophil-mediated delivery significantly enhanced tumor accumulation of 6-shogaol, inhibited tumor growth, and induced apoptosis by suppressing neutrophil elastase (NE) expression. Notably, no significant systemic toxicity was observed. This neutrophil-hitchhiking albumin nanoplatform provides a targeted and biocompatible strategy for effective colon cancer therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an 710061, China
Funding
National Science Foundation of Shaanxi
References (34)
Show source-provided references
1. Recent advances in clinical practice: Colorectal cancer chemoprevention in the average-risk population10.1136/gutjnl-2020-320990 ↗
2. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies10.1038/s41575-019-0189-8 ↗
3. Rising incidence of early-onset colorectal cancer—A call to action10.1038/s41571-020-00445-1 ↗
4. Clinical Updates for Colon Cancer Care in 2022
5. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis10.1053/j.gastro.2023.04.029 ↗
6. Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer10.1186/s12943-023-01830-x ↗
7. Targeting the tumour vasculature: From vessel destruction to promotion10.1038/s41568-024-00736-0 ↗
8. Pinkiewicz, M., Zaczyński, A., Walecki, J., and Zawadzki, M. (2025). Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood–Brain Barrier and Blood–Tumor Barrier. Int. J. Mol. Sci., 26.10.3390/ijms26157050 ↗
9. Biodegradable zwitterionic polymer membrane coating endowing nanoparticles with ultra-long circulation and enhanced tumor photothermal therapy10.1016/j.biomaterials.2019.119680 ↗
10. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release10.1016/j.addr.2024.115239 ↗
11. Engineering Macrophages for Cancer Immunotherapy and Drug Delivery10.1002/adma.202002054 ↗
12. The Neutrophil’s Role During Health and Disease10.1152/physrev.00012.2018 ↗
13. Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke10.1126/sciadv.aax7964 ↗
14. Targeted Delivery of Nanoparticle-Conveyed Neutrophils to the Glioblastoma Site for Efficient Therapy10.1021/acsami.4c05691 ↗
15. Engineering and Targeting Neutrophils for Cancer Therapy10.1002/adma.202310318 ↗
16. Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment10.1021/acsnano.4c12917 ↗
17. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis10.1016/j.cell.2021.04.016 ↗
18. Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis10.1136/gutjnl-2024-334618 ↗
19. Nanotechnology: A New Strategy for Lung Cancer Treatment Targeting Pro-Tumor Neutrophils10.1016/j.eng.2022.11.006 ↗
20. Cancer-induced systemic pre-conditioning of distant organs: Building a niche for metastatic cells10.1038/s41568-024-00752-0 ↗
21. Suarez-Lopez, L., Kong, Y.W., Sriram, G., Patterson, J.C., Rosenberg, S., Morandell, S., Haigis, K.M., and Yaffe, M.B. (2021). MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer. Front. Immunol., 11.10.3389/fimmu.2020.607891 ↗
22. Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents10.1002/ptr.6858 ↗
23. Anticancer perspective of 6-shogaol: Anticancer properties, mechanism of action, synergism and delivery system10.1186/s13020-023-00839-0 ↗
24. Integrated network pharmacology and cellular assay for the investigation of an anti-obesity effect of 6-shogaol10.1016/j.foodchem.2021.131755 ↗
25. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db/db mice10.1016/j.biopha.2017.10.084 ↗
26. Orally biomimetic metal-phenolic nanozyme with quadruple safeguards for intestinal homeostasis to ameliorate ulcerative colitis10.1186/s12951-024-02802-z ↗
27. Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy10.1186/s12951-022-01421-w ↗
28. Sensory neuron dysfunction in orthotopic mouse models of colon cancer10.1186/s12974-022-02566-z ↗
29. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver10.1016/j.ccell.2021.03.004 ↗
30. Neutrophil chemoattractant receptors in health and disease: Double-edged swords10.1038/s41423-020-0412-0 ↗
31. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy10.1016/j.canlet.2019.11.009 ↗
32. A Bifunctional Lysosome-Targeting Chimera Nanoplatform for Tumor-Selective Protein Degradation and Enhanced Cancer Immunotherapy10.1002/adma.202417942 ↗
33. Neutrophil-like pH-responsive pro-efferocytic nanoparticles improve neurological recovery by promoting erythrophagocytosis after intracerebral hemorrhage10.7150/thno.90370 ↗
34. Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD2410.1136/jitc-2024-010813 ↗